ISS
NVO

Intesa Sanpaolo SpA.’s Novo Nordisk NVO Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Buy
14,325
+1,700
+13% +$73K 0.02% 143
2026
Q1 		$464K Sell
12,625
-800
-6% -$37.9K 0.03% 136
2025
Q4 		$688K Buy
+13,425
New +$687K 0.04% 134

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Intesa Sanpaolo SpA.'s NVO Position: Q2 2026 in Review

Intesa Sanpaolo SpA. increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $73K and bringing the position to 14,325 shares worth $687K. The position accounts for 0.02% of the portfolio, ranked #143.

Intesa Sanpaolo SpA. first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $688K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Intesa Sanpaolo SpA. held 14,325 shares of Novo Nordisk worth $687K as of Q2 2026.
  • Intesa Sanpaolo SpA. bought 1,700 Novo Nordisk shares in Q2 2026, an estimated $73K.
  • Novo Nordisk made up 0.02% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #143 holding.
  • Intesa Sanpaolo SpA. first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo SpA.'s Novo Nordisk position peaked at $688K in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.